A citation-based method for searching scientific literature




Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull, Christopher P Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, David C Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M Brenner, Kenneth W Mahaffey. N Engl J Med 2019
Times Cited: 1487




List of shared articles



Times cited

Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.
Mohammad Shafi Kuchay, Khalid Jamal Farooqui, Sunil Kumar Mishra, Ambrish Mithal. Adv Exp Med Biol 2021
4

Factors that predict glycaemic response to sodium-glucose linked transporter (SGLT) inhibitors.
Amy L Harding, Naiara Bediaga, Anna Galligan, Peter G Colman, Spiros Fourlanos, John M Wentworth. Intern Med J 2021
0

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real-world clinical practice: Results of a 36-month post-marketing surveillance study (J-STEP/LT).
Kazunori Utsunomiya, Ryusuke Koshida, Seigo Kakiuchi, Masayuki Senda, Shoko Fujii, Yuji Kurihara, Ryoji Gunji, Kohei Kaku. J Diabetes Investig 2021
0


Glucagon in type 1 diabetes patients receiving SGLT2 inhibitors: A Friend or Foe?
Tomoyasu Fukui, Makoto Ohara, Sho-Ichi Yamagishi. Diabetes Metab Res Rev 2021
0

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Diabetes 2021
3

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Am J Kidney Dis 2021
11

Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy.
Biff F Palmer, Deborah J Clegg. Clin J Am Soc Nephrol 2021
1

Effect of sodium-glucose cotransporter-2 inhibitors on renal handling of electrolytes.
Priti Meena, Vinant Bhargava, Anil Bhalla, Devinder Rana, Alok Mantri. Postgrad Med J 2021
1

Identifying Risk Factors for Diabetic Ketoacidosis Associated with SGLT2 Inhibitors: a Nationwide Cohort Study in the USA.
Michael Fralick, Donald A Redelmeier, Elisabetta Patorno, Jessica M Franklin, Fahad Razak, Tara Gomes, Sebastian Schneeweiss. J Gen Intern Med 2021
1

Life-Threatening Complications Related to Delayed Diagnosis of Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Report of 2 Cases.
Shunsaku Goto, Jun-Ya Ishikawa, Masafumi Idei, Masahiro Iwabuchi, Motoki Namekawa, Takeshi Nomura. Am J Case Rep 2021
0



Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases.
Gaurav S Gulsin, Matthew P M Graham-Brown, Iain B Squire, Melanie J Davies, Gerry P McCann. Heart 2021
0

Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience.
K Zwart, S Velthuis, Y V Polyukhovych, A Mosterd, L Smidt, E H Serné, D H van Raalte, P J M Elders, M L Handoko, P C Oldenburg-Ligtenberg. Neth Heart J 2021
1

[Gliflozins-in future cardioprotective drugs?]
Ursula Rauch-Kröhnert, Ulf Landmesser. Internist (Berl) 2021
0

Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?
Abhinav Sharma, Haya Aziz, Subodh Verma, Beth L Abramson, Richard Choi, Grace L Chua, Kim A Connelly, George Honos, G B John Mancini, Sarah A Ramer,[...]. Curr Opin Cardiol 2021
0

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) as a Primary Preventative Agent in the Healthy Individual: A Need of a Future Randomised Clinical Trial?
Dan Xu, Owain Chandler, Cleo Wee, Chau Ho, Jacquita S Affandi, Daya Yang, Xinxue Liao, Wei Chen, Yanbing Li, Christopher Reid,[...]. Front Med (Lausanne) 2021
0


Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy.
Melissa-Rosina Pasqua, Michael A Tsoukas, Ahmad Haidar. J Diabetes Sci Technol 2021
0

Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes.
Renata Libianto, Timothy Me Davis, Elif I Ekinci. Med J Aust 2020
6

The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition.
Megan E Capozzi, Reilly W Coch, Jepchumba Koech, Inna I Astapova, Jacob B Wait, Sara E Encisco, Jonathan D Douros, Kimberly El, Brian Finan, Kyle W Sloop,[...]. Diabetes 2020
13

A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibition.
Idrisu Sanusi, Alexander Sarnowski, David Russell-Jones, Lui G Forni. J Crit Care 2020
0

Dapagliflozin-Induced Acute Pancreatitis: A Case Report and Review of Literature.
Sunam M Sujanani, Mohanad M Elfishawi, Paria Zarghamravanbaksh, Francisco J Cuevas Castillo, David M Reich. Case Rep Endocrinol 2020
2

Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study.
Avivit Cahn, Itamar Raz, Marc Bonaca, Ofri Mosenzon, Sabina A Murphy, Ilan Yanuv, Aliza Rozenberg, John P H Wilding, Deepak L Bhatt, Darren K McGuire,[...]. Diabetes Obes Metab 2020
10

Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.
Tanya Wilcox, Christophe De Block, Arthur Z Schwartzbard, Jonathan D Newman. J Am Coll Cardiol 2020
15


Combination therapy with SGLT2 inhibitors for diabetic kidney disease.
Yuwen Cai, Xin Liu, Gaosi Xu. Biomed Pharmacother 2020
3

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.
Sandeep R Das, Brendan M Everett, Kim K Birtcher, Jenifer M Brown, James L Januzzi, Rita R Kalyani, Mikhail Kosiborod, Melissa Magwire, Pamela B Morris, Joshua J Neumiller,[...]. J Am Coll Cardiol 2020
58